You are here

Disable VAT on Taiwan

Unfortunately, as of 1 January 2020 SAGE Ltd is no longer able to support sales of electronically supplied services to Taiwan customers that are not Taiwan VAT registered. We apologise for any inconvenience. For more information or to place a print-only order, please contact uk.customerservices@sagepub.co.uk.

JRSM Cardiovascular Disease

JRSM Cardiovascular Disease


eISSN: 20480040 | ISSN: 20480040 | Current volume: 12 | Current issue: 1 Frequency: Yearly

JRSM Cardiovascular Disease is a peer-reviewed journal which focuses on the pathology, epidemiology, prevention, treatment, and control of all aspects of cardiovascular diseases. Please see the Aims and Scope tab for further information.

From 1st September 2024 JRSM Cardiovascular Disease will convert to a Hybrid publication model. Peer review processes remain unchanged and authors can choose to publish Open Access via Sage Choice or through an agreement with their institution, if available. Articles submitted from the 1st September will be published, if accepted, under a Sage exclusive license. For further information please visit the Submission Guidelines: https://journals.sagepub.com/author-instructions/cvd.

This journal is a member of the Committee on Publication Ethics (COPE).

Submission information

Submit your manuscript today at https://mc.manuscriptcentral.com/cvd.

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Contact

Please direct any queries to albert.ferro@kcl.ac.uk.

JRSM Cardiovascular Disease is a peer-reviewed journal devoted to the pathology, epidemiology, prevention, treatment and control of all aspects of cardiovascular diseases. The journal aims to support the cardiovascular research community by providing a forum for basic, clinical and translational research in the field. JRSM Cardiovascular Disease was originally founded by the Royal Society of Medicine, and is supported by a prestigious Editorial Board to provide expert and timely peer review.

The journal welcomes research in the following areas:

  • Genomics
  • Stem cells and regeneration
  • Bioengineering and tissue repair
  • Transplantation
  • Cardiac and brain imaging
  • Hypertension
  • Organogenesis
  • Developments in therapies
  • Pharmacology
  • Physiology

Please direct any inquiries to the Editor-in-Chief, Prof Albert Ferro (albert.ferro@kcl.ac.uk).

Editor-in-Chief
Albert Ferro King’s College London, UK
Associate Editors
Orina Belton University College Dublin, Ireland
Marina Cecelja King's College London, UK
David Chambers King's College London, UK
Gheorghe A. Dan University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
Mohammad T. Hussain UT Southwestern Medical Center, USA
Jubin Joseph Keck School of Medicine,University of Southern California, USA
Chao Li The University of Hong Kong, Hong Kong
Arduino Mangoni Flinders Medical Centre and Flinders University, Bedford Park, Australia
Carmel McEniery Cambridge University, UK
Pietro Minuz University of Verona, Italy
Peter O'Kane Royal Bournemouth Hospital, UK
Tiffany Patterson Guy's and St Thomas NHS Foundation Trust, UK
Prakash Saha King's College London, UK
Yap-Hang Will Chan The University of Hong Kong, Hong Kong
International Editorial Board
Yousif Ahmad University of California, San Francisco, USA
Bernard Cheung The University of Hong Kong, Hong Kong
Jaspal Kooner Imperial College London, UK
Chu-Pak Lau University of Hong Kong, Hong Kong
James Meschia Mayo Clinic, USA
Peter Psaltis University of Adelaide, Australia
Antoni Martínez Rubio Hospital de Sabadell, Autonomous University of Barcelona, Spain
Pankaj Sharma Royal Holloway University of London, UK
Kai-Hang Yiu The University of Hong Kong, Hong Kong
  • Google Scholar: h-5 index - 11, h-5 median - 13
  • ProQuest
  • PubMed
  • Manuscript submission guidelines can be accessed on Sage Journals.

    Institutional Subscription, E-access